Meilleure Health International Industry Group stock closed at HK$0.24, with recent returns over the past week and month slightly in the red and the 90 day move deeper in decline. Yet H1 2026 earnings landed with a headline that is hard to ignore. Revenue for the period came in at HK$164.57m and net income reached HK$28.34m, which feeds into a trailing 12 month profit profile that investors may wish to weigh carefully in light of the recent share price weakness.

Love the fresh profit profile from Meilleure Health International Industry Group but concerned about the recent share price weakness and volatility? Check out the list of solid balance sheet and fundamentals stocks (427 results) for ideas that pair earnings with sturdier fundamentals.

H1 2026 Earnings Summary

• Revenue H1 2026 vs. H1 2025: HK$164.57m vs. HK$17.45m (very large increase in reported revenue for Meilleure Health International Industry Group)
• Net Income H1 2026 vs. H1 2025: HK$28.34m vs. HK$15.16m (higher reported profit period on period)
• Basic EPS H1 2026 vs. H1 2025: HK$0.007 vs. HK$0.0037 (higher earnings per share for the half year)
• Net Profit Margin Trailing 12 Months: 27.9%, compared with a prior-year margin at a higher level (current margin is lower than the earlier period)

Prefer clean visuals over another wall of figures and footnotes? See Meilleure Health International Industry Group's recent profitability in a full visual breakdown through the company report for Meilleure Health International Industry Group.

Meilleure Health earnings and the bullish angles

For investors leaning positive on Meilleure Health International Industry Group, the H1 2026 report gives some support. Revenue of HK$164.57m and net income of HK$28.34m, alongside a trailing 12 month net margin of 27.9%, point to a business currently earning a profit rather than just selling a thematic story. The improvement in basic EPS compared with H1 2025 suggests recent execution has been accretive at the per share level, which helps when the broader narrative leans on healthcare and wellness as potential long term drivers.

Where the Meilleure Health bear case still bites

Bears will focus on the gap between profit delivery and recent share price performance. The stock is down around 1% over 7 days, 2% over 30 days and 16% over 90 days, which signals ongoing market caution despite the profit print. The trailing margin is lower than the prior year, so profitability is not moving in a straight line. Combined with the company’s mix of healthcare, trading, property and investments, that softening margin leaves room for concerns about earnings quality and consistency across its many segments.

After a period of softer margins and earnings pressure, it is fair to ask if Meilleure Health International Industry Group has deeper structural issues. Review our independent risk analysis for Meilleure Health International Industry Group which shows 3 important warning signs

Stay Ahead With Simply Wall St

If the recent profit profile at Meilleure Health International Industry Group has your attention but the share price weakness keeps you cautious, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and wait for a setup that fits your plan. Once you are invested, use the Portfolio Command Center to cut through market noise and focus on concise, relevant updates about the companies you actually own. For a broader view, join the Community to see how other investors are thinking about opportunities and risks across the market. This combination helps you surface hidden catalysts and potential red flags earlier so you can stay ahead of the next move.

Seeking Alternatives Beyond Meilleure Health

Fresh opportunities can move from under the radar to full breakout faster than many investors expect. Use these focused lists while the momentum is still forming.

• Spot strong balance sheets early by scanning the curated list of solid balance sheet and fundamentals stocks (427 results) that filters for financial strength and fundamentals.
• Consider early AI momentum by checking the hand picked 136 AI small caps that highlight companies building traction in this space.
• Target resilient income ideas by reviewing the focused 417 dividend fortresses that highlights higher yielding stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.